Head-To-Head Comparison: Ramsay Health Care (OTCMKTS:RMYHY) vs. biote (NASDAQ:BTMD)

biote (NASDAQ:BTMD) and Ramsay Health Care (OTCMKTS:RMYHY) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Insider and Institutional Ownership

21.7% of biote shares are held by institutional investors. 32.4% of biote shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares biote and Ramsay Health Care”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
biote	$183.53 million	0.31	$27.05 million	$0.11	14.27
Ramsay Health Care	N/A	N/A	N/A	N/A	N/A

biote has higher revenue and earnings than Ramsay Health Care.

Analyst Recommendations

This is a breakdown of current recommendations for biote and Ramsay Health Care, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
biote	1	1	1	1	2.50
Ramsay Health Care	1	1	0	1	2.33

biote currently has a consensus price target of $2.50, suggesting a potential upside of 59.24%. Given biote’s stronger consensus rating and higher possible upside, research analysts clearly believe biote is more favorable than Ramsay Health Care.

Profitability

This table compares biote and Ramsay Health Care’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
biote	3.19%	-22.33%	12.10%
Ramsay Health Care	N/A	N/A	N/A

Risk and Volatility

biote has a beta of 1.64, indicating that its share price is 64% more volatile than the S&P 500. Comparatively, Ramsay Health Care has a beta of -0.11, indicating that its share price is 111% less volatile than the S&P 500.

Summary

biote beats Ramsay Health Care on 9 of the 10 factors compared between the two stocks.

About biote

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

About Ramsay Health Care

Ramsay Health Care Limited owns and operates hospitals. The company offers health care services to public and private patients. It operates facilities in approximately 530 locations in the Asia Pacific, the United Kingdom, France, and Nordics. Ramsay Health Care Limited was founded in 1964 and is based in Sydney, Australia.